Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo

Nature Medicine

Volumn 11, Issue 11, 2005, Pages 1188-1196

  Chen, Juhua ^a   Somanath, Payaningal R ^a   Razorenova, Olga ^a   Chen, William S ^b   Hay, Nissim ^b   Bornstein, Paul ^c   Byzova, Tatiana V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; THROMBOSPONDIN 1; THROMBOSPONDIN 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; BONE MARROW; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENDOTHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTINS; ANIMALS; AORTA; BLOOD VESSELS; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; COLLAGEN; DRUG COMBINATIONS; FEMALE; ISOENZYMES; LAMININ; LUNG; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; THROMBOSPONDIN 1; THROMBOSPONDINS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA;

EID: 30744432102     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1307     Document Type: Article

References (45)

1. Risau, W. Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31 (1995).
3. Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653-660 (2003).
4. Jiang, B.H., Zheng, J.Z., Aoki, M. & Vogt, P.K. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc. Natl. Acad. Sci. USA 97, 1749-1753 (2000).
5. Kandel, E.S. & Hay, N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253, 210-229 (1999).
6. Chen, W.S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (2001).
7. Peng, X.D. et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 17, 1352-1365 (2003).
8. O'neill, B.T. & Abel, E.D. Akt1 in the cardiovascular system: friend or foe? J. Clin. Invest. 115, 2059-2064 (2005).
9. Shiojima, I. et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J. Clin. Invest. 115, 2108-2118 (2005).
10. Byzova, T.V. et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol. Cell 6, 851-860 (2000).
11. Ruoslahti, E. & Engvall, E. Integrins and vascular extracellular matrix assembly. J. Clin. Invest. 99, 1149-1152 (1997).
12. Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583 (2001).
13. Byzova, T.V. et al. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99, 4434-4442 (2002).
14. Tammela, T., Enholm, B., Alitalo, K. & Paavonen, K. The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550-563 (2005).
15. Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511-2514 (1999).
16. Agah, A., Kyriakides, T.R., Lawler, J. & Bornstein, P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am. J. Pathol. 161, 831-839 (2002).
17. Bornstein, P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107, 929-934 (2001).
18. Chen, J. et al. Impaired platelet responses to thrombin and collagen in AKT-1 deficient mice. Blood 104, 1703-1710 (2004).
19. Ackah, E. et al. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115, 2119-2127 (2005).
20. Mazure, N.M., Chen, E.Y., Laderoute, K.R. & Giaccia, A.J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90, 3322-3331 (1997).
21. Arsham, A.M., Plas, D.R., Thompson, C.B. & Simon, M.C. Akt and hypoxia-inducible factor-1 independently enhance tumor growth and angiogenesis. Cancer Res. 64, 3500-3507 (2004).
22. Yu, J. et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc. Natl. Acad. Sci. USA 102, 10999-11004 (2005).
23. van Hinsbergh, V.W., Collen, A. & Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann. NY Acad. Sci. 936, 426-437 (2001).
24. Aicher, A. et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376 (2003).
25. Hotary, K.B. et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33-45 (2003).
26. Puolakkainen, P.A., Brekken, R.A., Muneer, S. & Sage, E.H. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol. Cancer Res. 2, 215-224 (2004).
27. Visse, R. & Nagase, H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839 (2003).
28. Simantov, R. & Silverstein, R.L. CD36: a critical anti-angiogenic receptor. Front. Biosci. 8, s874-s882 (2003).
29. Rodriguez-Manzaneque, J.C. et al. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA 98, 12485-12490 (2001).
30. Armstrong, L.C. et al. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism. Mol. Biol. Cell 13, 1893-1905 (2002).
31. Lange-Asschenfeldt, B. et al. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99, 538-545 (2002).
32. Bornstein, P., Agah, A. & Kyriakides, T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 36, 1115-1125 (2004).
33. Shiojima, I. & Walsh, K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90, 1243-1250 (2002).
34. Sun, J.F. et al. Microvascular patterning is controlled by fine-tuning the Akt signal. Proc. Natl. Acad. Sci. USA 102, 128-133 (2005).
35. Nagoshi, T. et al. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J. Clin. Invest. 115, 2128-2138 (2005).
36. Reynolds, L.E. et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8, 27-34 (2002).
37. Dong, Q.G. et al. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17, 1599-1604 (1997).
38. Byzova, T.V., Kim, W., Midura, R.J. & Plow, E.F. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp. Cell Res. 254, 299-308 (2000).
39. De, S. et al. Molecular pathway for cancer metastasis to bone. J. Biol. Chem. 278, 39044-39050 (2003).
40. Narizhneva, N.V. et al. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J. 19, 1158-1160 (2005).
41. De, S. et al. VEGF-integrin interplay controls tumor growth and vascularization. Proc. Natl. Acad. Sci. USA 102, 7589-7594 (2005).
42. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438 (1999).
43. Han, E.D., MacFarlane, R.C., Mulligan, A.N., Scafidi, J. & Davis, A.E., III. Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J. Clin. Invest. 109, 1057-1063 (2002).
44. Stockton, R.A., Schaefer, E. & Schwartz, M.A. p21-activated kinase regulates endothelial permeability through modulation of contractility. J. Biol. Chem. 279, 46621-46630 (2004).
45. Soula-Rothhut, M. et al. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. Exp. Cell Res. 304, 187-201 (2005).